Familial clustering of risk factors for cardiovascular disease among first-degree relatives of patients with chronic kidney disease in a sub-Saharan African population

Cardiovascular Journal of Africa

Volumn 26, Issue 2, 2015, Pages S11-S14

  Raji, Yemi ^a   Mabayoje, Omolara ^b   Bello, Taslim ^b  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b UNIVERSITY OF LAGOS   (Nigeria)

Author keywords

Cardiovascular disease; Chronic kidney disease; Firstdegree relatives; Risk factors; Sub Saharan Africa

Indexed keywords

ADULT; AFRICA SOUTH OF THE SAHARA; AFRICAN; ALBUMINURIA; ANTHROPOMETRY; ARTICLE; BIOCHEMICAL ANALYSIS; BLOOD PRESSURE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENDOCRINE FUNCTION; FAMILY HISTORY; FEMALE; FIRST DEGREE RELATIVE; HEALTH SURVEY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; URINALYSIS; VENOUS BLOOD; ADOLESCENT; BLACK PERSON; CARDIOVASCULAR DISEASES; COMPLICATION; MIDDLE AGED; PHYSIOLOGY; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; AFRICAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; YOUNG ADULT;

EID: 84930031623     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: 10.5830/CVJA-2015-041     Document Type: Article

References (30)

1. World Health Organization, 2009. Cardiovascular Diseases. http://www.who.int/mediacentre/factsheets/fs317/en/. Accessed Dec 20, 2014.
2. World Health Organization 2005. Preventing chronic diseases: a vital investment. http://www.who.int/chp/chronic-disease-report/contents/en. Accessed Dec 20, 2014.
3. Gaziano TA. Economic burden and the cost-effectiveness of treatment of cardiovascular disease in Africa. Heart 2008; 94(2): 140-144.
4. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367(9524): 1747-1757.
5. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3(11): e442.
6. Manjunath G, Tighiouart H, Coresh J, Macleod B, Salem DN, Griffith JL, et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int 2003; 63(3): 1121-1129.
7. Keith DS, Nicholas GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164(6): 659-663.
8. Mathew S, Tustison KS, Sugatani T, Chaudhary LR, Rifas L, Hruska KA. The mechanism of phosphorus as a cardiovascular risk factor in CKD. J Am Soc Nephrol 2008; 19: 1092-1105.
9. Mann JF, Gerstein HC, Yi QL, Lonn EM, Hoogwerf BJ, Rashkow A, et al. Development of renal disease in people at high cardiovascular risk: Results of the HOPE randomized study. J Am Soc Nephrol 2003; 14: 641-647.
10. Menon V, Sarnak MJ. The epidemiology of chronic kidney disease stages 1 to 4 and cardiovascular disease: A high risk combination. Am J Kidney Dis 2005; 45: 223-232.
11. Satko SG, Sedor JR, Iyengar SK, Freedman BI. Familial clustering of chronic kidney disease. Semin Dial 2007; 20(3): 229-236.
12. Satko SG, Freedman BI, Moossavi S. Genetic factors in end-stage renal disease. Kidney Int Suppl 2005; 94: S46-49.
13. Inssera FDG, Alpino AMS. Relatives of dialysis patients with increased risk of renal failure. Medicina (Beunos Aires) 2007; 67(1): 8-18.
14. Tsai JC, Chen SC, Hwang SJ, Chang JM, Lin MY, Chen HC. Prevalence and risk factors for CKD in spouses and relatives of haemodialysis patients. Am J Kidney Dis 2010; 55(3): 78-104.
15. Wei X, Li Z, Chen W, Mao H, Li Z, Dong X, et al. Prevalence and risk factors of chronic kidney disease in first-degree relatives of chronic kidney disease patients in southern, China. Nephrol Carlton 2012; 17(2): 123-130.
16. Salkeld G, Phongsavan P, Oldenburg B, Johannesson M, Convery P, Graham Clarke P, et al. The cost-effectiveness of a cardiovascular risk reduction program in general practice. Health policy (New York). Ireland: Elsevier Sci Ltd, 1997; 41(2): 105-119.
17. Brunner E, Cohen D, Toon L. Cost effectiveness of cardiovascular disease prevention strategies: a perspective on EU food based dietary guidelines. Public Health Nutr 2001; 4(2B): 711-715.
18. Chamnan P, Simmons RK, Khaw K-T, Wareham NJ, Griffin SJ. Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling study. Br Med J 2010; 340: c1693.
19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130(6): 461-470. http://www.qxmd.com/calculate-online/nephrology/mdrd-egfr. Accessed September 24, 2014.
20. WHO guideline on prevention, detection and treatment of diabetes mellitus, 2007. http://www.who.int/diabetes/publications/en/. Accessed September 12, 2014.
21. WHO/ISH Hypertension guidelines, 2005. http://www.who.int/cardiovascular-diseases/guidelines/hypertension/en/. Accessed September 12, 2014.
22. WHO | Obesity and overweight [Internet]. World Health Organisation Media Centre fact sheet No. 311. 2012. http://www.who.int/mediacentre/factsheets/fs311/en. Accessed October 18, 2014.
23. Waist circumference and waist-hip ratio. Report of a WHO expert consultation, 2008. http://www.who.int/nutrition/publications/obesity/WHO-report-waistcircumference-and-waisthip-ratio/en/. Accessed October 18, 2014.
24. Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen, W, Paccaud F, et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC public Health 2004; 34: 1473-1482.
25. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. J Am Med Assoc 2001; 285(19): 2486-2497.
26. Morse RM, Flavin DK. The definition of alcoholism. The Joint Committee of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism. J Am Med Assoc 1992; 268: 1012.
27. Husten CG. How should we define light or intermittent smoking? Does it matter? Nicotine Tob Res 2009; 11: 111-121.
28. Oyegbade OO, Abioye-Kuteyi EA, Kolawole BA, Ezeoma IT, Bello IS. Screening for Diabetes mellitus in a Nigerian family practice population. SA Fam Pract 2007; 49(8): 15-21.
29. Ogah OS, Okpechi I, Chukwuonye II, Akinyemi OJ, Onwubere BJC, Falase AO, et al. Blood pressure, prevalence of hypertension and hypertension related complications in Nigerian Africans: A review. World J Cardiol 2012; 4(12): 327-340.
30. Mvo Z, Dick J, Steyn K. Perceptions of overweight African women about acceptable body size of women and children. Curationis 1999; 22(2): 27-31.